Structure-activity relationship of the cardenolides derived from digoxigenin and digitoxigenin, with special reference to the configuration at C-5.
作者信息
Ishikawa N, Tsuru H, Shigei T, Anjyo T, Okada M
出版信息
Experientia. 1974 Nov 15;30(11):1308-10. doi: 10.1007/BF01945201.
PMID:4435176
Abstract
摘要
相似文献
1
Structure-activity relationship of the cardenolides derived from digoxigenin and digitoxigenin, with special reference to the configuration at C-5.洋地黄毒苷元和地芰毒苷元衍生的强心苷的构效关系，特别涉及C-5位的构型
Experientia. 1974 Nov 15;30(11):1308-10. doi: 10.1007/BF01945201.
2
Cardiotonic activities of 3,5-seco-4-nor-cardenolides in Rana nigromaculata.黑斑蛙中3,5-断-4-去甲强心甾类化合物的强心活性
Experientia. 1975 Aug 15;31(8):955-6. doi: 10.1007/BF02358874.
3
Cardiotonic activities of some new type of bufadienolide- and cardenolide-conjugates.某些新型蟾蜍二烯羟酸内酯和强心甾烯糖苷缀合物的强心活性
Experientia. 1977 Feb 15;33(2):258-60. doi: 10.1007/BF02124098.
4
Behaviour of cardiac glycosides and cardenolides related to digitoxigenin on sephadex LH-20.洋地黄毒苷配基相关的强心苷和蟾蜍甾二烯类化合物在葡聚糖凝胶LH - 20上的行为
J Chromatogr. 1975 Dec 10;115(1):117-21. doi: 10.1016/s0021-9673(00)89023-8.
5
Cardenolide analogs. V. Cardiotonic activity of semisynthetic analogs of digitoxigenin.强心甾内酯类似物。V. 洋地黄毒苷元半合成类似物的强心活性。
J Pharmacol Exp Ther. 1974 Nov;191(2):219-31.
6
Cardiotonic activities of 4 new compounds derived from digitoxigenin and uzarigenin, and their structure-activity relationship.由洋地黄毒苷元和乌沙苷元衍生的4种新化合物的强心活性及其构效关系。
Experientia. 1968 May 15;24(5):466-7. doi: 10.1007/BF02144395.
7
Studies on cardioactive steroids. I. Structure-activity relationships on the isolated atrium.强心甾体类化合物的研究。I. 对离体心房的构效关系
Pharmacology. 1974;11(2):117-26. doi: 10.1159/000136476.
8
Synthetic cardenolides.合成强心甾类化合物。
Adv Carbohydr Chem Biochem. 1966;21:273-321. doi: 10.1016/s0096-5332(08)60319-7.
9
Cardiotonic action of ring A-modified cardenolides, with special reference to cleavage of the ring.A环修饰强心甾类化合物的强心作用，特别涉及环的裂解
Jpn J Pharmacol. 1977 Dec;27(6):799-805. doi: 10.1254/jjp.27.799.
10
Na, K-activated ATPase activity during and after arrhythmic response to AY-22-241 in the canine heart.犬心脏对AY - 22 - 241心律失常反应期间及之后的钠钾激活ATP酶活性
Ann N Y Acad Sci. 1974;242(0):671-82. doi: 10.1111/j.1749-6632.1974.tb19125.x.
引用本文的文献
1
Lipophilicity and pharmacodynamics of cardiotonic steroids in guinea-pig isolated heart muscle preparations.强心甾类化合物在豚鼠离体心肌制剂中的亲脂性和药效学
Br J Pharmacol. 1988 Feb;93(2):281-8. doi: 10.1111/j.1476-5381.1988.tb11432.x.
2
Cardiotonic activities of 3,5-seco-4-nor-cardenolides in Rana nigromaculata.黑斑蛙中3,5-断-4-去甲强心甾类化合物的强心活性
Experientia. 1975 Aug 15;31(8):955-6. doi: 10.1007/BF02358874.
3
Cardiac glycosides: prerequisites for the development of new cardiotonic compounds.强心苷：新型强心化合物研发的先决条件。
Experientia. 1977 Jun 15;33(6):697-703. doi: 10.1007/BF01944136.
本文引用的文献
1
Structure-activity relationships of several cardiotonic steroids with respect to inhibition of ion transport in frog muscle.几种强心甾类化合物对蛙肌离子转运抑制作用的构效关系。
J Gen Physiol. 1969 Aug;54(2):268-84. doi: 10.1085/jgp.54.2.268.
2
Cardiotonic activities of 4 new compounds derived from digitoxigenin and uzarigenin, and their structure-activity relationship.由洋地黄毒苷元和乌沙苷元衍生的4种新化合物的强心活性及其构效关系。
Experientia. 1968 May 15;24(5):466-7. doi: 10.1007/BF02144395.
3
Cardiotonic action of 3-deoxydigitoxigenin.3-去氧洋地黄毒苷元的强心作用。
Experientia. 1970 Aug 15;26(8):867-8. doi: 10.1007/BF02114228.
4
Structure-activity relationship of the cardenolide, with special reference to the substituents and configurations at C-14 and C-15.强心甾内酯的构效关系，特别涉及C-14和C-15位的取代基及构型
Experientia. 1973 Apr 15;29(4):449-50. doi: 10.1007/BF01926775.
5
[Molecular biological assessment of digitalis type compounds].[洋地黄类化合物的分子生物学评估]
Planta Med. 1971:Suppl 4:66-78. doi: 10.1055/s-0028-1099726.
Zotero 插件